Article
Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLC.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Feb 2021
Zheng Mei-Mei, Li Yang-Si, Tu Hai-Yan, Jiang Ben-Yuan, Yang Jin-Ji, Zhou Qing, Xu Chong-Rui, Yang Xiao-Rong, Wu Yi-Long
Abstract excerpt
INTRODUCTION: Patients with NSCLC with leptomeningeal metastases (LM) presented dismal prognosis. Cerebrospinal fluid (CSF) is suggested as a medium of liquid biopsy of LM. However, the clinical implications of CSF genotyping on treatment outcomes remained elusive. METHODS: Patients with EGFR-mutated advanced NSCLC with LM were included: cohort 1, patients with LM who were treated with osimertinib with CSF and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
